Anal canal cancer
To develop HRQoL module for metastatic and recurrent/ persistent anal cancer
Who can joinAdults
Age18+ years
Kind of studyObservational: no new treatment
What it testsWatches and records only
The full list of who can and cannot join is on the registry. Ask the trial team, or write to us and we will explain it in simple words.
Last updated on the registry 3 Feb 2025. Please confirm with the hospital that this trial is still taking patients.
Contact hospital
The registry names this hospital as the trial's main contact. Ask them which hospitals are taking patients.
Tata Memorial CentreMumbaiDirections ↗
Registry summary (technical)
A feasibility study to develop a HRQoL module for metastatic and recurrent/ persistent anal cancer or to add metastatic anal cancer-specific items to the existing EORTC QLQ-ANL27 - NIL
Sponsor: European Organisation for Research and Treatment of Cancer
CTRI/2024/04/066464 on CTRI, India's trial registry
Source: Clinical Trials Registry – India (CTRI), via WHO ICTRP, data of 12 Oct 2026
Last updated on the registry 3 Feb 2025 · read by us 5 Nov 2026